
ARD-266 is a a highly мощный and VHL E3 ligase-based androgen рецептор (AR) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR-positive LNCaP, VCaP, and 22Rv1 prostate cancer клетка lines with DC50 values of 0.2-1 nM.
ARD-266 is a a highly potent and VHL E3 ligase-based androgen receptor (AR) PROTAC degrader. ARD-266 effectively induces degradation of AR protein in AR-positive LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC50 values of 0.2-1 nM.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.